FDA Approves Camzyos for the Treatment of Obstructive Hypertrophic Cardiomyopathy
Mavacamten is the first ever drug to be approved for HOCM found to improve symptoms and may reduce the need for surgery for some people.
Sitaramesh Emani Institute For Clinical Ohio State University Wexner Medical Center First Medication That Addresses Underlying Disease Process Comes With
Source: everydayhealth.com